New clinical findings reveal that Ocitum delivers 21% oral bioavailability, more than double the typical ~10% seen in conventional herbal extracts, setting a new standard for absorption and efficacy.
Beyond superior bioavailability, the study highlights a rapid onset of action within just 30 minutes, followed by up to 4 hours of sustained calmness, addressing one of the most critical gaps in the stress and mood category, speed with longevity.
"These pharmacokinetic findings represent a meaningful step forward for botanical ingredients — demonstrating that superior bioavailability and predictable onset are achievable in a natural Holy Basil extract." - Munjaal Rupani (Business Development- International)
The data underscores a growing demand in the nutraceutical industry for ingredients backed by rigorous clinical science. Ocitum is designed for supplement, functional food and beverage applications where efficacy, bioavailability and consumer trust are non-negotiable.
To explore the science behind Ocitum and its latest clinical advancements, visit our booth (3A154) at Vitafoods Europe.
